Jones Day advised Amolyt Pharma on the deal. Amolyt Pharma (“Amolyt,” “Amolyt Pharma” or the “Company”), a global company specialized in developing innovative therapies for rare...
You must be a Standard 1 Year member to access this content.
Goodwin advised Sofinnova Partners, Intermediate Capital Group, Tekla et CTI Life Sciences. Jones Day advised Amolyt Pharma. McDermott Will & Emery advised Andera Partners, Novo Holdings...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Sectoral Asset Management and Andera Partners on the deal. McDermott Will & Emery advised a syndicate of Amolyt Pharma’s historical investors, including LSP,...
You must be a Standard 1 Year member to access this content.
